Status:
RECRUITING
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Prostate Cancer
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study focuses on the scientific and clinical evaluation of online adaptive radiotherapy (ART) using the Varian/SHS ETHOS treatment system. In this study, radiation treatment plans are dynamically ...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years)
- All tumor entities with an indication for radiotherapy and/or chemoradiotherapy
- Signed informed consent
Exclusion
- Pregnancy
- Patients who are not capable of giving consent
Key Trial Info
Start Date :
October 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 9 2027
Estimated Enrollment :
649 Patients enrolled
Trial Details
Trial ID
NCT06116019
Start Date
October 11 2023
End Date
October 9 2027
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin
Berlin, Germany